Sante Capital Fund’s Nutanix NTNX Stock Holding History

Sante Capital Fund’s Portfolio NTNX Stock Details NTNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-41,678	Closed	-$1.59M	–	80
2021 Q2	$1.59M	Buy	+41,678	New	+$1.3M	0.66%	29

Other funds holding NTNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sante Capital Fund's NTNX Position: Q3 2021 in Review

Sante Capital Fund sold out of Nutanix (NTNX) in Q3 2021, closing a stake of 41,678 shares — an estimated $1.59M sold.

Sante Capital Fund first reported a position in NTNX in Q2 2021 and held it in 1 quarter. The position peaked at $1.59M in Q2 2021. 321 funds tracked by Wall St. Rank hold NTNX as of Q3 2021.

Sante Capital Fund reported no remaining Nutanix position as of Q3 2021 after selling out during the quarter.
Sante Capital Fund sold 41,678 Nutanix shares in Q3 2021, an estimated $1.59M.
Sante Capital Fund first reported a position in Nutanix in Q2 2021 and held it in 1 quarter.
Sante Capital Fund's Nutanix position peaked at $1.59M in Q2 2021.
321 funds tracked by Wall St. Rank held Nutanix as of Q3 2021.

Based on Sante Capital Fund's 13F filing for Q3 2021, filed 15 Nov 2021.